EBS
NYSE
$7.69
Emergent Biosolutions Inc (EBS)
Emergent BioSolutions Inc., a life sciences company, focuses on providing preparedness and response products and solutions for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHT). The company is headquartered in Gaithersburg, Maryland.
Sector:
Healthcare
Buy
Target: $12 (+56.05%)
Market Cap
$408M
PEG Ratio
0.38
P/B Ratio
0.79
Free Cash Flow Yield
33.17%
Price Chart
Valuation
Market Cap$408M
Forward P/E2.08
PEG0.38
P/S0.57
P/B0.79
Profitability
Total Revenue (TTM)$677M
Gross Profit (TTM)$321M
EBITDA$155M
Profit Margin4.4%
Operating Margin6.7%
EPS-$0.17
Financial Health
Debt-to-Equity109.7%
Free Cash Flow Yield33.17%
Growth & Risk
Revenue 5Y CAGR-16.88%
FCF 5Y CAGR-15.29%
Beta (5Y)1.88
Sharpe Ratio0.41